Reducing body myopathy - A new pathogenic FHL1 variant and literature review.
Mota IA, Correia CDC, Fontana PN, Carvalho AAS.
Neuromuscul Disord. 2021 Sep;31(9):847-853. doi: 10.1016/j.nmd.2021.03.013. Epub 2021 Apr 15.
FHL1-mutated reducing body myopathy.
Lim KY, Kim HH, Sung JJ, Oh BM, Kim K, Park SH.
Neuropathology. 2020 Apr;40(2):185-190. doi: 10.1111/neup.12619. Epub 2019 Dec 5.
Reducing body myopathy and other FHL1-related muscular disorders.
Schessl J, Feldkirchner S, Kubny C, Schoser B.
Semin Pediatr Neurol. 2011 Dec;18(4):257-63. doi: 10.1016/j.spen.2011.10.007.
Reducing body myopathy.
Brooke MH, Neville HE.
Neurology. 1972 Aug;22(8):829-40. doi: 10.1212/wnl.22.8.829.
Inclusion body myositis: evolving concepts.
Perez-Rosendahl M, Mozaffar T.
Curr Opin Neurol. 2022 Oct 1;35(5):604-610. doi: 10.1097/WCO.0000000000001095.
Delayed onset muscle soreness : treatment strategies and performance factors.
Cheung K, Hume P, Maxwell L.
Sports Med. 2003;33(2):145-64. doi: 10.2165/00007256-200333020-00005.
Reducing body myopathy associated with the LIM2 p.(His123Arg) FHL1 variant.
Darki L, Jalali-Sohi A, Guzman S, Mathew AJ, Bucelli RC, Hurth KM, Beydoun SR.
Clin Neurol Neurosurg. 2021 Aug;207:106795. doi: 10.1016/j.clineuro.2021.106795. Epub 2021 Jul 7.
Achilles Tendinopathy: Pathophysiology, Epidemiology, Diagnosis, Treatment, Prevention, and Screening.
Knapik JJ, Pope R.
J Spec Oper Med. 2020 Spring;20(1):125-140. doi: 10.55460/QXTX-A72P.
[Reducing body myopathy].
Ishikawa H, Nishino I.
Ryoikibetsu Shokogun Shirizu. 2001;(35):424-6.
[Myopathy, reducing body].
Nishino I.
Ryoikibetsu Shokogun Shirizu. 2001;(34 Pt 2):255-6.
